Home › Core › ISCC-IDs › 28C316mfmFabM

View ISCC-ID

Core Data

28C316mfmFabM
ISCC-ID - digital asset identifier
CC9wZjWUstwiZ-CTvZnp7u4dG58-CDrdXGvnpsA6p-CRbLJSSBdTtVY
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

1year results of combined halfdose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy

Ledger Reference

coblo
Source Ledger/Blockchain
5851
N-th ISCC Decleration on source ledger
29cadcb0737085879095537a5ca726f7493c3aad968bba8a09a848be3a3bf9fa
Hash of block that includes the ISCC-DECLARATION
caa6ba9e9633ba71078f8b1c20361c75b54cfdabecb06bbc6c520e69fdb396ba
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ian Y. Wong", "@type": "Person"}, {"name": "Xuan Shi", "@type": "Person"}, {"name": "Rita Gangwani", "@type": "Person"}, {"name": "Paul Zhao", "@type": "Person"}, {"name": "Lawrence P. Iu", "@type": "Person"}, {"name": "Qing Li", "@type": "Person"}, {"name": "Alex Ng", "@type": "Person"}, {"name": "Xiaoxin Li", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4485362?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1186/s12886-015-0061-8", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CC9wZjWUstwiZ-CTvZnp7u4dG58-CDrdXGvnpsA6p-CRbLJSSBdTtVY", "propertyID": "ISCC"}], "datePublished": "2015-06-30"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close